Navigation Links
Genesis Pharmaceuticals Received New Purchase Orders Worth $12 Million
Date:9/11/2008

LAIYANG, China, Sept. 11 /Xinhua-PRNewswire-FirstCall/ -- Genesis Pharmaceuticals Enterprises, Inc. (OTC Bulletin Board: GNPH) ("Genesis" or the "Company"), a leading pharmaceutical company in the People's Republic of China, today announced that the Company received purchase orders for a total value of approximately $12 million over the next 12 months from over 800 wholesale distributors at the 43rd Annual New Drugs Conference (the "Conference") sponsored by China Health Tech Forum 2008.

The 43rd Annual New Drugs Conference was held on September 3rd - 5th in Yantai International Expo Center, Shandong Province. The purpose of this industry Conference was to allow pharmaceutical companies in China with new and innovative products to meet and exchange ideas, and to allow pharmaceutical companies to introduce their products to distributors. Genesis distributed a large number of Company brochures at the Conference and received numerous inquiries from distributors.

The Company's newly developed Radix Isatidis Dispersible Tablets, an herbal-based traditional Chinese medicine, received the highest number of orders, over 60% of the total value of the purchase orders.

"We are pleased that the 43rd Annual New Drugs Conference was such a success for the Company. We believe that these new purchase orders from these distributors will increase our presence in the Chinese over the counter pharmaceuticals market," said Mr. Cao Wubo, Chairman and CEO of Genesis Pharmaceuticals Enterprises. "We hope to expand our market share and get even greater brand recognition in China in the future by bringing new and innovative products to market."

About Genesis Pharmaceuticals Enterprises, Inc.

Genesis Pharmaceuticals Enterprises, Inc. is a U.S. public company engaged in the research, development, production, marketing and sales of pharmaceutical products in the People's Republic of China. Its operations are located in Northeast China in an Economic Dev
'/>"/>

SOURCE Genesis Pharmaceuticals Enterprises, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Pathway links inflammation, angiogenesis and breast cancer
2. EURYI project to understand how the brain wires during embryogenesis
3. DNA damage response confers a barrier for viral tumorigenesis
4. ThermoGenesis Announces 510(k) Clearance for AutoXpress(TM) Cord Blood Processing System
5. The genetics of MLL leukemogenesis
6. Genesis Technology Group Retains CCG Elite
7. Researchers chart the genetic mechanisms behind the genesis of fat cells
8. Tissue Genesis Signs Exclusive Distribution and License Agreement with SpineSmith
9. ThermoGenesis Corp. Reports First Quarter 2008 Results
10. Cardiogenesis Receives FDA Approval for PEARL 5.0 Robotic Hand Piece
11. Genesis Pharmaceuticals Announces Results for The First Quarter of Fiscal Year 2008

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)... simple question has been the focus of intense res...ulates High Blood Pressure in Mice & Men, Does st...n has been the focus of intense research for many ...tablished a link between a novel gene, phosducin, ...as well as humans. The studies were directed by sc...
(Date:11/25/2009)...atment clinics to resume Monday, Nov. 30 , ...009 -- Centegra Health System is continuing to off...our Centegra Primary Care (CPC) vaccination clinic...he clinics are at CPC sites in Huntley, Woodstock,...ows: ,   From 4:30 to 7:30 p.m. Tuesda...
(Date:11/25/2009)... trouble with the H1N1 vaccine, , , WED...N1 swine flu pandemic may be driving a recent spik...a U.S. health official said Wednesday. , "We ar...tions around the country," Dr. Anne Schuchat, dire...espiratory Diseases at the U.S. Centers for Diseas...
(Date:11/25/2009)...aightYear ,, WASHINGTON,Nov.25/PRNewswire-USN...A)issuedthe 4thAnnualReportCardonLungCancer .ThisR...ethaldiseaseinthestateofGeorgia.LCA-GAisachapterof...ndedicatedexclusivelytopatientsupportandadvocacyfo...o: http://www.newscom.com/cgi-bin/prnh/20081016/LC...
(Date:11/25/2009)...ur in children with autism and related conditions ... medication combined with a structured training pr...searchers and their colleagues. , Published in ...rican Academy of Child and Adolescent Psychiatry ,... of Mental Health (NIMH) Research Units on Pediatr...
Breaking Medicine News(10 mins):Health News:New stress-related gene modulates high blood pressure in mice and men 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4Health News:Swine Flu Tied to Rise in Pneumonias Among Young 2Health News:Swine Flu Tied to Rise in Pneumonias Among Young 3Health News:Swine Flu Tied to Rise in Pneumonias Among Young 4Health News:Lung Cancer Alliance-Georgia Issues 4th Annual State-Specific Report Card on Lung Cancer 2Health News:Parent training key to improved treatment of behavior problems in children with autism 2
...elhi Chief Minister Sheila Dikshit Monday launched...ll in the capital.// The mission "would not ... would also lay equal importance to aspects of pre...d reliable primary healthcare service and effectiv...
...ews of interest for post menopausal women with bre...-addition of both Herceptin (trastuzumab) from Roc...o their treatment improves the length of progressi... after which the cancer continued to progress. ...
...tem cells to reverse the signs of aging are now th...re skeptical about the significance of the stem ce...ne lines. "The whole stem cell thing is by f... much." He said that researchers are "in the...
...remature births appear to be a bigger threat to ba...ccording to a new study from the U.S. Centers// fo...infant deaths in 2002 were linked to prematurity, ...h of Dimes' Perinatal Data Center, said, "We have ...
...oughing vigorously until an ambulance arrives coul..., said researchers.// Tadeusz Petelenz and c...ce, Poland, studied 115 people who had previously ...ecognise the symptoms - sudden dizziness and weakn...
...o understand the influence of economic, social and...State researchers have designed an index labeled ‘...ssociate professor of criminal justice, and Dr. St...f the Journal of Black Studies. "There are m...
Other Medicine News:Health News:Stem Cells –To Lift Wrinkle 2Health News:One third of Infant Deaths from Premature Births in U.S. 2Health News:Understanding Stress Triggers for African Americans 2
(Date:11/24/2009)...d.,Nov.24/PRNewswire-Asia/--ChindexInternational,I...AmericanproviderofWestern,healthcareproductsandser...hattheCompanywillattendthe21stAnnualPiperJaffray,"...,2009,atthe,NewYorkPalaceHotel. , Managementi...December1,2009,andholdone-on-onemeetingsthroughout...
(Date:11/24/2009)...J.,Nov.24/PRNewswire-FirstCall/--QuestDiagnosticsI...fdiagnostictesting,informationandservices,announce...ayHealthcareConferenceinNewYorkCity.Thepresentatio...asternTime. ,, Duringtheconference,thecompanywi...mate3%,operatingincometoexceed18%ofrevenues,anddil...
(Date:11/24/2009)...AKE,N.J.andNEWYORK,Nov.24/PRNewswire/-- EisaiInc....ministration(FDA)hasacceptedforreviewEisai,sNewDru...epezilHClextendedrelease)tabletsforthetreatmentofm...rdoseformulationcontains23mgofdonepezilHClinanexte...atallowsforgradualreleaseofthedrug.TheNDAisbasedon...
Breaking Medicine Technology:Chindex International to Present at Piper Jaffray Health Care Conference 2Quest Diagnostics To Speak At The 21st Annual Piper Jaffray Healthcare Conference 2FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review 2FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review 3Soyfoods a Healthy Choice for Men 48575 1Soyfoods a Healthy Choice for Men 48575 2Soyfoods a Healthy Choice for Men 48575 3Soyfoods a Healthy Choice for Men 48575 4Transcept Pharmaceuticals Announces Expected FDA Extension of Regulatory Review Period for Intermezzo 28R 29 48570 1Transcept Pharmaceuticals Announces Expected FDA Extension of Regulatory Review Period for Intermezzo 28R 29 48570 2Transcept Pharmaceuticals Announces Expected FDA Extension of Regulatory Review Period for Intermezzo 28R 29 48570 3Transcept Pharmaceuticals Announces Expected FDA Extension of Regulatory Review Period for Intermezzo 28R 29 48570 4Haemacure Reports on Strategic Collaboration with Angiotech Pharmaceuticals Inc and Second Quarter 2009 Financial Results 48565 1Haemacure Reports on Strategic Collaboration with Angiotech Pharmaceuticals Inc and Second Quarter 2009 Financial Results 48565 2Haemacure Reports on Strategic Collaboration with Angiotech Pharmaceuticals Inc and Second Quarter 2009 Financial Results 48565 3Haemacure Reports on Strategic Collaboration with Angiotech Pharmaceuticals Inc and Second Quarter 2009 Financial Results 48565 4
...il 16 Simbionix, the world,s leading,developer of...reement with,Johnson & Johnson LLC for distrib...ts. , Johnson & Johnson, LLC operates in R... subsidiaries of Johnson & Johnson. , John...o distribute,Simbionix,s line of advanced medical ...
...The following letter is being released by CEL-SCI ...s: , , Dear Fellow Shareholders: , , A very imp... Dendreon Corporation has announced that its pivot...et its primary endpoint of improving overall survi...from the 512 patient study will be presented on Ap...
Other Medicine Technology:Simbionix and Johnson & Johnson LLC Announce Distribution Agreement at Russia and the CIS Countries 2CEL-SCI Corporation Releases Letter to Shareholders 2CEL-SCI Corporation Releases Letter to Shareholders 3
Ocular Four Mirror Mini Gonio
Ocular Single Mirror Gonio
Mcintyre Straight Lachrymal Cannula
McIntyre Lacrimal Cannula
Medicine Products: